<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - PROMETHAZINE HYDROCHLORIDE</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>PROMETHAZINE HYDROCHLORIDE</h1>


      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#renalImpairment" data-toggle="tab">Renal impairment</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#importantSafetyInformation" data-toggle="tab">Important safety information</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#unlicensedUse" data-toggle="tab">Unlicensed use</a></li>
          <li><a href="#lessSuitableForPrescribing" data-toggle="tab">Less suitable for prescribing</a></li>
          <li><a href="#professionSpecificInformation" data-toggle="tab">Profession specific information</a></li>
          <li><a href="#exceptionsToLegalCategory" data-toggle="tab">Exceptions to legal category</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Symptomatic relief of allergy such as hay fever and urticaria</span>,
                <span class="indication">Insomnia associated with urticaria and pruritus</span>,
            </h4>
            <p class="specificity"><span class="route">By deep intramuscular injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                10&#8211;20 mg 2&#8211;3 times a day.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                25&#8211;50 mg (max. per dose 100 mg).</li>
              <li class="dose child"><strong>For children 2&#8211;4 years</strong><br/>
                5 mg twice daily, alternatively 5&#8211;15 mg once daily, dose to be taken at night.</li>
              <li class="dose child"><strong>For children 5&#8211;9 years</strong><br/>
                5&#8211;10 mg twice daily, alternatively 10&#8211;25 mg once daily, dose to be taken at night.</li>
              <li class="dose child"><strong>For children 10&#8211;17 years</strong><br/>
                10&#8211;20 mg 2&#8211;3 times a day, alternatively 25 mg once daily, dose to be taken at night, increased if necessary to 25 mg twice daily.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Emergency treatment of anaphylactic reactions</span>,
            </h4>
            <p class="specificity"><span class="route">By slow intravenous injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                25&#8211;50 mg, to be administered as a solution containing 2.5 mg/mL in water for injections; maximum 100 mg per course.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Sedation (short-term use)</span>,
            </h4>
            <p class="specificity"><span class="route">By deep intramuscular injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                25&#8211;50 mg.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                25&#8211;50 mg.</li>
              <li class="dose child"><strong>For children 2&#8211;4 years</strong><br/>
                15&#8211;20 mg.</li>
              <li class="dose child"><strong>For children 5&#8211;9 years</strong><br/>
                20&#8211;25 mg.</li>
              <li class="dose child"><strong>For children 10&#8211;17 years</strong><br/>
                25&#8211;50 mg.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Nausea</span>,
                <span class="indication">Vomiting</span>,
                <span class="indication">Vertigo</span>,
                <span class="indication">Labyrinthine disorders</span>,
                <span class="indication">Motion sickness</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                20&#8211;25 mg, to be taken at bedtime on night before travel, repeat following morning if necessary.</li>
              <li class="dose child"><strong>For children 2&#8211;4 years</strong><br/>
                5 mg, to be taken at bedtime on night before travel, repeat following morning if necessary.</li>
              <li class="dose child"><strong>For children 5&#8211;9 years</strong><br/>
                10 mg, to be taken at bedtime on night before travel, repeat following morning if necessary.</li>
              <li class="dose child"><strong>For children 10&#8211;17 years</strong><br/>
                20&#8211;25 mg, to be taken at bedtime on night before travel, repeat following morning if necessary.</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
      </section>



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <p>Most manufacturers of antihistamines advise avoiding their use during pregnancy; however, there is no evidence of teratogenicity.</p><p>Use in the latter part of the third trimester may cause adverse effects in neonates such as irritability, paradoxical excitability, and tremor.</p>
            </section>
      </section>

      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

            <section class="generalInformation">
              <p>Avoid in severe liver disease&#8212;increased risk of coma.</p>
            </section>
      </section>

      <section class="tab-pane" id="renalImpairment">
        <h2>Advice regarding renal impairment</h2>

        
            <section class="generalInformation">
              <p>Use with caution.</p>
            </section>
      </section>

      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

          <ul>
            <li>Many antihistamines should be avoided in <xref format="dita" href="#PHP78608" type="bookmark" namespace="/treatment-summaries/acute-porphyrias">Acute porphyrias</xref> but promethazine is thought to be safe.</li>
            <li><strong>neonates:</strong> neonate (due to significant antimuscarinic activity) in neonates</li>
            <li><strong>children:</strong> should not be given to children under 2 years, except on specialist advice, because the safety of such use has not been established in children</li>
          </ul>
      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

          <h3>General side effects</h3>
              <p>
                <strong>rare:</strong> Anaphylaxis, angioedema, angle-closure glaucoma, arrhythmias, blood disorders, bronchospasm, confusion, convulsions, depression, dizziness, extrapyramidal effects, hypersensitivity reactions, hypotension, liver dysfunction, palpitation, photosensitivity reactions, rashes, sleep disturbances, tremor,
              </p>
              <p>
                <strong>notKnown:</strong> Antimuscarinic effects, blurred vision, drowsiness, dry mouth, gastro-intestinal disturbances, headache, psychomotor impairment, restlessness, urinary retention,
              </p>
        
          <h3>Specific side effects</h3>
              <p>
                <strong>notKnown:</strong> injection pain in adults,
              </p>
        
            <section class="advice">
              <h3 class="specificity">In adults</h3>
              <p>Elderly patients are more susceptible to side-effects.</p>
            </section>
            <section class="advice">
              <h3 class="specificity">In children</h3>
              <p>Children are more susceptible to side-effects.</p>
            </section>
            <section class="advice">
              <h3 class="specificity">In adults</h3>
              <p>Drowsiness is a significant side-effect with most of the older antihistamines although paradoxical stimulation may occur rarely, especially with high doses or in children and the elderly. Drowsiness may diminish after a few days of treatment and is considerably less of a problem with the newer antihistamines.</p>
            </section>
            <section class="advice">
              <h3 class="specificity">In children</h3>
              <p>Drowsiness is a significant side-effect with most of the older antihistamines although paradoxical stimulation may occur rarely in children, especially with high doses. Drowsiness may diminish after a few days of treatment and is considerably less of a problem with the newer antihistamines.</p>
            </section>
        
      </section>


      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

      </section>


      <section class="tab-pane" id="importantSafetyInformation">
        <h2>Important safety information</h2>

            <section class="importantSafetyInformation">
                <h3>MHRA/CHM advice (March 2008 and February 2009) Over-the-counter cough and cold medicines for children</h3>
              <p>Children under 6 years should not be given over-the-counter cough and cold medicines containing promethazine.</p>
            </section>
      </section>

      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
            Epilepsy
          </li>
          <li>
              <strong>:</strong>
            prostatic hypertrophy in adults
          </li>
          <li>
            pyloroduodenal obstruction
          </li>
          <li>
            severe coronary artery disease
          </li>
          <li>
            susceptibility to angle-closure glaucoma
          </li>
          <li>
            urinary retention
          </li>
        </ul>
        <ul>
          <li>
              <strong>With intravenous use:</strong>
            avoid extravasation with intravenous injection
          </li>
        </ul>
      </section>



      <section class="tab-pane" id="unlicensedUse">
        <h2>Unlicensed use</h2>

            <section class="unlicensedUse">
              <h3 class="specificity">In children</h3>
              <p>Not licensed for use for sedation in children under 2 years.</p>
            </section>
      </section>




      <section class="tab-pane" id="lessSuitableForPrescribing">
        <h2>Conditions when less suitable for prescribing</h2>

            <section class="lessSuitableForPrescribing">
              <p>Promethazine is less suitable for prescribing for sedation.</p>
            </section>
      </section>



      <section class="tab-pane" id="professionSpecificInformation">
        <h2>Profession specific information</h2>

          <h3>Dental practitioners</h3>
        
            <section class="dentalPractitionersFormulary">
              <p>Promethazine Hydrochloride Tablets 10&#8239;mg or 25&#8239;mg may be prescribed.</p><p>Promethazine Hydrochloride Oral Solution (elixir) 5&#8239;mg/5&#8239;mL may be prescribed.</p>
            </section>
      </section>

      <section class="tab-pane" id="exceptionsToLegalCategory">
        <h2>Exceptions to legal category</h2>

            <section class="exceptionsToLegalCategory">
              <p>Prescription only medicine restriction does not apply to promethazine hydrochloride injection where administration is for saving life in emergency.</p>
            </section>
      </section>


      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of PROMETHAZINE HYDROCHLORIDE</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        
          <strong>Forms available from special-order manufacturers include: </strong>
            oral solution,
            oral suspension,

            <div id="PHP75802"><a href="../medicinalForm/PHP75802.html" data-target="#PHP75802" data-action="load">Tablet</a></div>
            <div id="PHP75809"><a href="../medicinalForm/PHP75809.html" data-target="#PHP75809" data-action="load">Oral solution</a></div>
            <div id="PHP75822"><a href="../medicinalForm/PHP75822.html" data-target="#PHP75822" data-action="load">Solution for injection</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
